His scientific interests lie mostly in Neuroscience, Internal medicine, Endocrinology, Amygdala and Extinction. His Locus coeruleus, Periaqueductal gray and Neurochemical study in the realm of Neuroscience interacts with subjects such as Voltage-gated ion channel. His work in Internal medicine is not limited to one particular discipline; it also encompasses Elevated plus maze.
His research in Endocrinology intersects with topics in Neuropeptide, Receptor, Glutamate receptor and Neuropeptide Y receptor. The various areas that Nicolas Singewald examines in his Extinction study include Anxiety, Psychiatry, Phobias and Fear processing in the brain. His Anxiety study combines topics in areas such as Developmental psychology and Clinical psychology.
His primary areas of investigation include Internal medicine, Endocrinology, Neuroscience, Anxiety and Amygdala. The study incorporates disciplines such as Elevated plus maze and Taurine in addition to Internal medicine. Nicolas Singewald interconnects Glutamate receptor and Serotonin in the investigation of issues within Endocrinology.
His research is interdisciplinary, bridging the disciplines of Exposure therapy and Neuroscience. His research integrates issues of Developmental psychology and Clinical psychology in his study of Anxiety. His biological study spans a wide range of topics, including Infralimbic cortex, Periaqueductal gray and Premovement neuronal activity.
His main research concerns Neuroscience, Anxiety, Extinction, Internal medicine and Endocrinology. His Neuroscience research is multidisciplinary, incorporating perspectives in Neuropeptide S and Exposure therapy. His study in the field of Anxiolytic is also linked to topics like Biomarker and Mi-2/NuRD complex.
Nicolas Singewald combines subjects such as Fear conditioning, Amygdala, Endophenotype, Anxiety disorder and Phobias with his study of Extinction. The concepts of his Internal medicine study are interwoven with issues in Oncology and Neuron. His study in Endocrinology is interdisciplinary in nature, drawing from both Agonist and Receptor.
Nicolas Singewald spends much of his time researching Neuroscience, Extinction, Anxiety, Exposure therapy and Amygdala. His Neuroscience research is multidisciplinary, incorporating elements of Neuropeptide S and Internal medicine. His work on Circadian rhythm, Ultradian rhythm and Fluoxetine as part of general Internal medicine research is frequently linked to CLOCK and PER2, bridging the gap between disciplines.
His Circadian rhythm study is related to the wider topic of Endocrinology. His study in the field of Anxiolytic also crosses realms of Stress. His work in the fields of Basolateral amygdala overlaps with other areas such as PTEN, Downregulation and upregulation and In situ hybridization.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Neuronal circuits of fear extinction.
Cyril Herry;Francesco Ferraguti;Nicolas Singewald;Johannes J. Letzkus.
European Journal of Neuroscience (2010)
Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs.
Nicolas Singewald;Peter Salchner;Trevor Sharp.
Biological Psychiatry (2003)
Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.
N. Singewald;C. Schmuckermair;N. Whittle;A. Holmes.
Pharmacology & Therapeutics (2015)
The role of substance P in stress and anxiety responses
K. Ebner;N. Singewald.
Amino Acids (2006)
Impaired Fear Extinction Learning and Cortico-Amygdala Circuit Abnormalities in a Common Genetic Mouse Strain
Kathryn Hefner;Nigel Whittle;Jaynann Juhasz;Maxine Norcross.
The Journal of Neuroscience (2008)
Substance P in the medial amygdala: Emotional stress-sensitive release and modulation of anxiety-related behavior in rats
Karl Ebner;Nadia M. Rupniak;Alois Saria;Nicolas Singewald.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Release of neurotransmitters in the locus coeruleus
Nicolas Singewald;Athineos Philippu.
Progress in Neurobiology (1998)
Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment.
S.B. Sartori;N. Whittle;A. Hetzenauer;N. Singewald.
Isoform-specific regulation of mood behavior and pancreatic beta cell and cardiovascular function by L-type Ca 2+ channels.
Martina J. Sinnegger-Brauns;Alfred Hetzenauer;Irene G. Huber;Erik Renström.
Journal of Clinical Investigation (2004)
Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: Focus on vasopressin and glyoxalase-I
Rainer Landgraf;Melanie S. Kessler;Mirjam Bunck;Chris Murgatroyd.
Neuroscience & Biobehavioral Reviews (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: